Make That 2 Biotech Stocks Today: Sabby Management Reveals It Bought Advaxis

Sabby Management, Advaxis: Advaxis, Inc. (NASDAQ:ADXS), a micro-cap biotech development company, has just seen Hal Mintz’s Sabby Management disclose a 6.3% stake. Earlier today, Sabby revealed it has joined Alpha Capital Anstalt in another small biotech player, DARA Biosciences Inc (NASDAQ:DARA). We’ll be watching this situation very closely.


Advaxis recently conducted a public offering of some 6.6 million shares and warrants at prices worth $4 per share of common stock, and $0.001 per warrant. The total gross proceeds after the offering amounted to $26.5 million.

Disclosure: none

Recommended Reading:

Is Icahn’s Case for Apple at $1,250 Flawed?

JHL Capital Ups Stake in Unisys to Above 5%

Hirzel Capital Just Bought More Hawaiian Holdings Stock at $7.40/Share